{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:24:13Z","timestamp":1777508653040,"version":"3.51.4"},"reference-count":50,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2019,5,17]],"date-time":"2019-05-17T00:00:00Z","timestamp":1558051200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosmedicine.org"],"crossmark-restriction":false},"short-container-title":["PLoS Med"],"DOI":"10.1371\/journal.pmed.1002784","type":"journal-article","created":{"date-parts":[[2019,5,17]],"date-time":"2019-05-17T13:22:30Z","timestamp":1558099350000},"page":"e1002784","update-policy":"https:\/\/doi.org\/10.1371\/journal.pmed.corrections_policy","source":"Crossref","is-referenced-by-count":4,"title":["Plasmodium vivax morbidity after radical cure: A cohort study in Central Vietnam"],"prefix":"10.1371","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7822-7059","authenticated-orcid":true,"given":"Thanh Vinh","family":"Pham","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4212-7056","authenticated-orcid":true,"given":"Hong Van","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3271-7028","authenticated-orcid":true,"given":"Angel Rosas","family":"Aguirre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Van Van","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario","family":"A. Cleves","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xa Xuan","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thao Thanh","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Duong Thanh","family":"Tran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hung Xuan","family":"Le","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1881-0637","authenticated-orcid":true,"given":"Niel","family":"Hens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0432-5203","authenticated-orcid":true,"given":"Anna","family":"Rosanas-Urgell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6341-5009","authenticated-orcid":true,"given":"Umberto","family":"D\u2019Alessandro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Niko","family":"Speybroeck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0522-4965","authenticated-orcid":true,"given":"Annette","family":"Erhart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2019,5,17]]},"reference":[{"issue":"8","key":"ref1","doi-asserted-by":"crossref","first-page":"e774","DOI":"10.1371\/journal.pntd.0000774","article-title":"The international limits and population at risk of Plasmodium vivax transmission in 2009","volume":"4","author":"CA Guerra","year":"2010","journal-title":"PLoS Negl Trop Dis"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/B978-0-12-397900-1.00004-9","article-title":"Diagnosis and treatment of Plasmodium vivax malaria","volume":"80","author":"KJ Baird","year":"2012","journal-title":"Adv Parasitol"},{"key":"ref3","unstructured":"Fleming M. FDA Approves Tafenoquine, First New P Vivax Malaria Treatment in 60 Years. Contagion Live. JUL 23, 2018 [cited 2018 Aug 16]. https:\/\/www.contagionlive.com\/news\/fda-approves-tafenoquine-first-new-treatment-of-p-vivax-malaria-in-60-years<\/ext-link>."},{"issue":"5","key":"ref4","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1128\/AAC.01296-10","article-title":"Resistance to chloroquine unhinges vivax malaria therapeutics","volume":"55","author":"JK Baird","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1186\/1475-2875-11-280","article-title":"Primaquine radical cure of Plasmodium vivax: a critical review of the literature","volume":"11","author":"GK John","year":"2012","journal-title":"Malar J"},{"key":"ref6","unstructured":"WHO. Guidelines for the treatment of malaria. Third edition. April 2015 [cited 2018 Mar 10]. http:\/\/www.who.int\/malaria\/publications\/atoz\/9789241549127\/en\/<\/ext-link>."},{"key":"ref7","unstructured":"WHO. World Malaria Report 2017 [cited 2018 Aug 16]. http:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/259492\/9789241565523-eng.pdf;jsessionid=0F04E7242F1B3AEFFCF70870D09674A1?sequence=1<\/ext-link>."},{"key":"ref8","unstructured":"The Government of Vietnam. National Strategy for malaria control and elimination 2011\u20132020 and orientation for 2030. Decision No. 1920\/Q\u0110-TTg dated of 27 October 2011 of the Prime Minister [cited 2017 Dec 21]. http:\/\/www.wpro.who.int\/vietnam\/topics\/malaria\/vnm_national_strategy_for_malaria_controlnelimination.pdf<\/ext-link>."},{"key":"ref9","unstructured":"National Malaria Control and Elimination Program (NMECP) in Vietnam. Malaria report from 2011 to 2015, Intenal Report. NIMPE, Hanoi 2016."},{"key":"ref10","unstructured":"National Malaria Control and Elimination Program (NMECP) in Vietnam. Malaria report from 1999 to 2016, Internal Report. NIMPE, Hanoi. 2016."},{"key":"ref11","unstructured":"Vietnam Ministry of Health: Guideline Surveillance and prevention of malaria disease. Hanoi, 2016 [cited 2017 Dec 21]. http:\/\/vncdc.gov.vn\/files\/Notice\/2016\/3\/quyet-dinh-741_qdbyt-ngay-0232016-huong-dan-giam-sat-va-phong-chong-sot-ret(2).pdf<\/ext-link>."},{"issue":"5","key":"ref12","doi-asserted-by":"crossref","first-page":"e1001642","DOI":"10.1371\/journal.pmed.1001642","article-title":"Communicating and monitoring surveillance and response activities for malaria elimination: China\u2032s "1-3-7" strategy","volume":"11","author":"J Cao","year":"2014","journal-title":"PLoS Med"},{"key":"ref13","unstructured":"Ministry of Health. Guideline of diagnosis, treatment and prevention malaria disease 2016 [cited 2017 Dec 25]. https:\/\/thuvienphapluat.vn\/van-ban\/The-thao-Y-te\/Quyet-dinh-4845-QD-BYT-Huong-dan-chan-doan-dieu-tri-benh-Sot-ret-2016-321533.aspx<\/ext-link>."},{"key":"ref14","unstructured":"Ministry of Health. Guideline of diagnosis, treatment and prevention malaria disease 2007 [cited 2017 Dec 25]. https:\/\/thuvienphapluat.vn\/van-ban\/The-thao-Y-te\/Quyet-dinh-339-QD-BYT-Huong-dan-chuan-doan-dieu-tri-benh-sot-ret-93442.aspx<\/ext-link>."},{"key":"ref15","unstructured":"Ministry of Health. Guideline of diagnosis, treatment and prevention malaria disease 2009 [cited 2017 Dec 25]. https:\/\/vanbanphapluat.co\/quyet-dinh-3232-qd-byt-2013-huong-dan-chan-doan-dieu-tri-benh-sot-ret<\/ext-link>."},{"key":"ref16","unstructured":"Thanh PV. Epidemiology of Plasmodium vivax malaria in Central Vietnam, PhD thesis 2018 [cited 2018 Oct 10]. https:\/\/dial.uclouvain.be\/pr\/boreal\/en\/object\/boreal%3A202970<\/ext-link>."},{"issue":"6","key":"ref17","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.4269\/ajtmh.2010.09-0521","article-title":"Adherence to 7-day primaquine treatment for the radical cure of P. vivax in the Peruvian Amazon","volume":"82","author":"KP Grietens","year":"2010","journal-title":"Am J Trop Med Hyg"},{"issue":"8","key":"ref18","doi-asserted-by":"crossref","first-page":"e1002379","DOI":"10.1371\/journal.pmed.1002379","article-title":"Unsupervised primaquine for the treatment of Plasmodium vivax malaria relapses in southern Papua: A hospital-based cohort study","volume":"14","author":"NM Douglas","year":"2017","journal-title":"PLoS Med"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/s12936-015-0601-y","article-title":"Epidemiology of forest malaria in Central Vietnam: the hidden parasite reservoir","volume":"14","author":"PV Thanh","year":"2015","journal-title":"Malar J"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1475-2875-7-11","article-title":"Distribution of Anopheles in Vietnam, with particular attention to malaria vectors of the Anopheles minimus complex","volume":"7","author":"C Garros","year":"2008","journal-title":"Malar J"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1186\/1475-2875-9-373","article-title":"Malaria transmission and vector behaviour in a forested malaria focus in central Vietnam and the implications for vector control","volume":"9","author":"W Van Bortel","year":"2010","journal-title":"Malar J"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1038\/ncomms2241","article-title":"Factors determining the occurrence of submicroscopic malaria infections and their relevance for control","volume":"3","author":"LC Okell","year":"2012","journal-title":"Nat Commun"},{"issue":"Suppl 1","key":"ref23","doi-asserted-by":"crossref","first-page":"S199","DOI":"10.1016\/S0035-9203(02)90077-5","article-title":"Alternative polymerase chain reaction method to identify Plasmodium species in human blood samples: the semi-nested multiplex malaria PCR (SnM-PCR)","volume":"96","author":"JM Rubio","year":"2002","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1186\/1475-2875-8-249","article-title":"Human Plasmodium knowlesi infections in young children in central Vietnam","volume":"8","author":"P Van den Eede","year":"2009","journal-title":"Malar J"},{"issue":"6","key":"ref25","doi-asserted-by":"crossref","first-page":"989","DOI":"10.4269\/ajtmh.2012.12-0047","article-title":"Marked age-dependent prevalence of symptomatic and patent infections and complexity of distribution of human Plasmodium species in central Vietnam","volume":"87","author":"HV Nguyen","year":"2012","journal-title":"Am J Trop Med Hyg"},{"key":"ref26","unstructured":"Tien NT. Reviewing the monitoring of antimalarial drug efficacy and resistance in sentinel sites in Vietnam. International Colloquium ITM\/NIMPE 2007 [cited 2017 Dec 21]. Abstract book p. 71 [71]. https:\/\/studylib.net\/doc\/8823884\/abstract-book<\/ext-link>."},{"issue":"1","key":"ref27","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1093\/ije\/dyu222","article-title":"Modelling recurrent events: a tutorial for analysis in epidemiology","volume":"44","author":"LD Amorim","year":"2015","journal-title":"Int J Epidemiol"},{"key":"ref28","unstructured":"Cleves M. Analysis of multiple failure-time survival data [cited 2017 Dec 21]. http:\/\/www.stata.com\/support\/faqs\/statistics\/multiple-failure-time-data\/<\/ext-link>."},{"key":"ref29","unstructured":"WHO. Status report on artemisinin resistance and ACT efficacy (August 2018) 2018 [cited 2018 Aug 16]. https:\/\/www.who.int\/malaria\/publications\/atoz\/artemisinin-resistance-august2018\/en\/<\/ext-link>."},{"key":"ref30","unstructured":"National Malaria Control and Elimination Program (NMECP) in Vietnam. Annual Malaria report, Internal report. NIMPE, Hanoi. 2018."},{"key":"ref31","unstructured":"National Malaria Control and Elimination Program (NMECP) in Vietnam. Annual Malaria report, Internal report. NIMPE, Hanoi. 2017."},{"issue":"4","key":"ref32","doi-asserted-by":"crossref","first-page":"715","DOI":"10.3201\/eid2304.161872","article-title":"Treatment Failure of Dihydroartemisinin\/Piperaquine for Plasmodium falciparum Malaria, Vietnam","volume":"23","author":"BQ Phuc","year":"2017","journal-title":"Emerg Infect Dis"},{"issue":"1","key":"ref33","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1186\/s12936-018-2380-8","article-title":"Quantifying primaquine effectiveness and improving adherence: a round table discussion of the APMEN Vivax Working Group","volume":"17","author":"K Thriemer","year":"2018","journal-title":"Malar J"},{"key":"ref34","unstructured":"Medicines for Malaria Venture (MMV). Tafenoquine 2018 [cited 2018 Oct 20]. https:\/\/www.mmv.org\/related-story-type\/tafenoquine<\/ext-link>."},{"issue":"5","key":"ref35","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S1473-3099(18)30046-X","article-title":"The persistence and oscillations of submicroscopic Plasmodium falciparum and Plasmodium vivax infections over time in Vietnam: an open cohort study","volume":"18","author":"TN Nguyen","year":"2018","journal-title":"Lancet Infect Dis"},{"issue":"5","key":"ref36","doi-asserted-by":"crossref","first-page":"529","DOI":"10.4269\/ajtmh.2003.69.529","article-title":"Comparison of artificial membrane feeding with direct skin feeding to estimate the infectiousness of Plasmodium vivax gametocyte carriers to mosquitoes","volume":"69","author":"J Sattabongkot","year":"2003","journal-title":"Am J Trop Med Hyg"},{"issue":"6","key":"ref37","doi-asserted-by":"crossref","first-page":"638","DOI":"10.4269\/ajtmh.2004.70.638","article-title":"A retrospective examination of the effect of fever and microgametocyte count on mosquito infection on humans infected with Plasmodium vivax","volume":"70","author":"WE Collins","year":"2004","journal-title":"Am J Trop Med Hyg"},{"issue":"1","key":"ref38","doi-asserted-by":"crossref","first-page":"e3413","DOI":"10.1371\/journal.pntd.0003413","article-title":"Systematic review of sub-microscopic P. vivax infections: prevalence and determining factors","volume":"9","author":"Q Cheng","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"issue":"4","key":"ref39","first-page":"229","article-title":"Some lacunae in our knowledge of the malaria parasite","volume":"9","author":"JA Sinton","year":"1955","journal-title":"Indian J Malariol"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1186\/1475-2875-10-297","article-title":"Determinants of relapse periodicity in Plasmodium vivax malaria","volume":"10","author":"NJ White","year":"2011","journal-title":"Malar J"},{"issue":"5","key":"ref41","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1093\/cid\/ciq249","article-title":"Plasmodium vivax recurrence following falciparum and mixed species malaria: risk factors and effect of antimalarial kinetics","volume":"52","author":"NM Douglas","year":"2011","journal-title":"Clin Infect Dis"},{"issue":"8567","key":"ref42","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1016\/S0140-6736(87)91479-6","article-title":"High rate of Plasmodium vivax relapse following treatment of falciparum malaria in Thailand","volume":"2","author":"S Looareesuwan","year":"1987","journal-title":"Lancet"},{"issue":"6","key":"ref43","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1097\/QCO.0b013e32834c61e3","article-title":"Plasmodium vivax treatments: what are we looking for?","volume":"24","author":"RN Price","year":"2011","journal-title":"Curr Opin Infect Dis"},{"issue":"12","key":"ref44","doi-asserted-by":"crossref","first-page":"7411","DOI":"10.1128\/AAC.00791-15","article-title":"Confirmed Plasmodium vivax Resistance to Chloroquine in Central Vietnam","volume":"59","author":"PV Thanh","year":"2015","journal-title":"Antimicrobial agents and chemotherapy"},{"issue":"11","key":"ref45","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1093\/infdis\/jis580","article-title":"Relapses contribute significantly to the risk of Plasmodium vivax infection and disease in Papua New Guinean children 1\u20135 years of age","volume":"206","author":"I Betuela","year":"2012","journal-title":"J Infect Dis"},{"key":"ref46","unstructured":"WHO. Guidelines for the treatment of malaria. Second Edition. 2010 [cited 2017 Dec 21]. http:\/\/apps.who.int\/medicinedocs\/documents\/s19105en\/s19105en.pdf<\/ext-link>.]"},{"issue":"9","key":"ref47","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1086\/424663","article-title":"Primaquine therapy for malaria","volume":"39","author":"JK Baird","year":"2004","journal-title":"Clin Infect Dis"},{"issue":"10","key":"ref48","first-page":"CD008492","article-title":"Artemisinin-based combination therapy for treating uncomplicated Plasmodium vivax malaria","author":"N Gogtay","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"ref49","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/S1473-3099(10)70079-7","article-title":"Artemisinin combination therapy for vivax malaria","volume":"10","author":"NM Douglas","year":"2010","journal-title":"Lancet Infect Dis"},{"key":"ref50","unstructured":"Mugenyi L, Herzog SA, Hens N, Abrams S. Modelling longitudinal binary outcomes with outcome- dependent observation times: an application to a malaria cohort study. BioRxiv 252411 [Preprint]. 2018 [cited 2018 Oct 30]. https:\/\/www.biorxiv.org\/content\/10.1101\/252411v1<\/ext-link>."}],"container-title":["PLOS Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pmed.1002784","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T19:36:25Z","timestamp":1588966585000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pmed.1002784"}},"subtitle":[],"editor":[{"given":"Elizabeth A","family":"Ashley","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2019,5,17]]},"references-count":50,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2019,5,17]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pmed.1002784","relation":{},"ISSN":["1549-1676"],"issn-type":[{"value":"1549-1676","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,17]]}}}